Next Article in Journal
Seed Germination and Seedling Growth Influenced by Genetic Features and Drought Tolerance in a Critically Endangered Maple
Next Article in Special Issue
Pharmacological and Chemical Analysis of Bauhinia divaricata L. Using an In Vitro Antiadipogenic Model
Previous Article in Journal
Quantifying Chilling Injury on the Photosynthesis System of Strawberries: Insights from Photosynthetic Fluorescence Characteristics and Hyperspectral Inversion
Previous Article in Special Issue
Cyclic Hexapeptide from Bouvardia ternifolia (Cav.) Schltdl. and Neuroprotective Effects of Root Extracts
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Flavonoid Composition and Antioxidant Activity of Tragia volubilis L. Methanolic Extract

by
Juan Carlos Romero-Benavides
1,*,
Nora Cecilia Atiencie-Valarezo
1 and
Rodrigo Duarte-Casar
2
1
Departamento de Química, Facultad de Ciencias Exactas y Naturales, Universidad Técnica Particular de Loja, Loja 110108, Ecuador
2
Maestría en Química Aplicada, Facultad de Ciencias Exactas y Naturales, Universidad Técnica Particular de Loja, Loja 110108, Ecuador
*
Author to whom correspondence should be addressed.
Plants 2023, 12(17), 3139; https://doi.org/10.3390/plants12173139
Submission received: 10 August 2023 / Revised: 27 August 2023 / Accepted: 29 August 2023 / Published: 31 August 2023

Abstract

:
Several species from the genus Tragia L. in the family Euphorbiaceae are part of the ethnomedicine of traditional cultures, and have a variety of uses. Tragia volubilis L. is a species spread through tropical America and Africa with several ethnomedical uses, particularly for wound healing and reproductive issues. In this study, we assess the phytochemical composition and antioxidant activity of the methanolic extract of the aerial parts of T. volubilis collected in southern Ecuador. The phytochemical screening of the extract shows the preliminary presence of carbohydrates, alkaloids, flavonoids, and tannins. The extract shows an Antioxidant Activity Index of 1.14, interpreted as strong antioxidant activity. Four flavonoid compounds were isolated through chromatographic procedures and identified through NMR spectroscopy: avicularin, quercitrin, afzelin, and amentoflavone. The biological activity of these compounds matches the ethnopharmacological uses of the species. This is the first phytochemical study of T. volubilis and supports its traditional medicinal uses.

Graphical Abstract

1. Introduction

Utilizing plants for medicinal purposes is prevalent among several animal species; great apes and humans are but examples of a widespread practice [1]. Humanity has harnessed the health-enhancing properties of plants since prehistoric times. Early evidence shows the use of medicinal plants by our Neanderthal ancestors [2]. Even today, about 80% of the world’s population relies on herbal medicines to preserve and promote their well-being [3].
Ethnopharmacology is an interdisciplinary field that studies the biologically active agents recognized and used by man and the cultural heritage that surrounds their use. It is an important drug discovery approach. Traditional wisdom has converged with modern research methods and tools, resulting in the validation of many ethnopharmacological claims and the development of new and improved drugs and treatments from traditional medicinal plants [4].

The Genus Tragia (Euphorbiaceae)

Euphorbiaceae is a plant family abundant in medicinal species. This abundance is attributed to the vast geographical distribution and, thus, the variety of environmental stressors that affect the species of the family, to which they react through the production of a variety of secondary metabolites [5]. Within this family, the Tragia Plum ex L. genus, present worldwide in the intertropical region, is traditionally used in African and Asian traditional medicinal systems, i.e., Ayurveda and Siddha [6], for a wide spectrum of ailments [7], as food [8], and for other uses, such as a low-toxicity irritant, evaluated as a riot control agent [9]. The species native to America are less studied, and, while traditionally used, do not seem to be part of documented medicinal systems. Around 26 of the more than 150 species in the genus are reported as medicinal, mostly as treatments for conditions of the genitourinary, nervous, and digestive systems, infections, and cancer. Most research to date focuses on four Asian and African species: Tragia involucrata Linn., Tragia spathulata Benth., Tragia benthamii Baker, and Tragia plukenetii Radcl. Research on the genus centers on antidiabetic and anti-inflammatory activity. Additionally, investigations have revealed significant biological activity and low toxicity in relation to its antimalarial, antibacterial, antitumor, and diuretic effects [10].
More than sixty New World Tragia species comprise almost 40% of the total species in the genus. Despite this abundance, less research has been conducted on the New World than on the Old World Tragia species, even though there is evidence of its use by First Nations [11] before the Hispanic contact [12]. The eight New World medicinal Tragia species mentioned in the literature and their uses are shown in Table 1, along with their uses.
In addition to medical uses, there are other reported activities of the New World species: T. biflora is allelopathic against water plants; pounded, boiled T. brevispica taken orally is reportedly aphrodisiac in Uganda [20]; and T. gracilis is used in Cuba for Santería religious uses [21].
Among the American species, the most widely distributed, and the lectotype chosen by Linnaeus for the genus [22], is T. volubilis, present not only in intertropical America and the Caribbean but also in West and Central Africa, where it is presumably an introduced species [23,24]. Its distribution is shown in Figure 1, encompassing the seasonally dry tropical biome from southern USA to Central Argentina in America and from Sudan to Zimbabwe in Africa.
The species is called “twining Tragia” in Jamaica due to its growth habit, and Pringamoza morada in Cuba due to its purple flowers [26]. Most of its vernacular names, such as “fireman” or “cowitch,” stem from the intense irritation it produces, due to its stinging hairs (raphides) tipped with calcium oxalate crystals that cause a painful, transient contact dermatitis that disappears, leaving no trace [27]. On contact irritation tests, the intensity of its sting is one out of three, equivalent to low intensity [28].
T. volubilis is a perennial, climbing herb or subshrub, either totally voluble or with voluble apexes, with simple, alternate, usually serrated leaves and simple, urticant hair pubescences. Paniculoid inflorescences are positioned terminally and opposite the leaves with 1- ∞ pistillate flowers. They consist of a main terminal axis with 3- ∞ staminate flowers and persistent bracts [29]. Figure 2 shows the serrated leaves and stinging hairs of the plant.
The species is part of the Maya tradition in Mesoamerica, where it is called “Quetzalcoatl’s herb,” where Quetzalcoatl or Kukulkan—the feathered serpent—is the supreme Maya deity. The plant twines like a serpent and is covered in “feathers”—actually raphides—to resemble the supernatural being [30]. In the sixteenth-century “History of the Plants of New Spain” by Francisco Hernández, it is said that its leaves “cure madness when drunk” [12]. The species is considered urticant, rubefacient, and medicinal. Its published ethnomedical uses are listed in Table 2.
T. volubilis is an insufficiently studied species. Most research on the species, searched through Dimensions [40] using “Tragia volubilis” on a full-text search, shows the species is mentioned in 168 publications, with ecology (78), plant biology (23), and both agriculture and environmental science (19) as major disciplines. There are no health sciences or chemical studies reported for the species directly. There is as yet no phytochemical study on this species, and there is no verification of its reported medicinal properties beyond its confirmed use as a diuretic [41,42].
The objective of this work is to provide a first phytochemical study of the species and to suggest preliminary molecular grounds for the reported ethnopharmacological uses.

2. Results and Discussion

The results of this phytochemical study of T. volubilis are as follows.

2.1. Extract

In total, 1987 g of fresh plant material yielded 1287 g of dried aerial parts of T. volubilis, from which 62.87 g of methanolic extract was obtained (yield: 7.39%). The yield is similar to those of methanolic extracts of other Euphorbiaceae species (4.11–8.85%) [43], and also comparable to T. involucrata leaf extract at 6.75% [44]. Most methanolic Tragia extracts reported are root extracts, mainly those of T. involucrata [45].

2.2. Phytochemical Screening

The methanolic extract of aerial parts of T. volubilis was subject to a preliminary phytochemical screening to show the compound classes present (Table 3). Terpenoids showed a scant presence; flavonoids and carbohydrates exhibited a moderate presence; and alkaloids and tannins showed a strong presence. These compound families are similar to those found in other Tragia species, such as Tragia involucrata L. [46,47], Tragia pungens (Forssk.) Müll. Arg. [48], and Tragia benthamii Baker [49].
Terpenoids, alkaloids, and flavonoids exhibit biological activity consistent with the ethnopharmacological uses reported for the species, notably antimicrobial action that could underlie wound healing, anti-STD, and anti-ulcer activity [50]. Flavonoids [51] and terpenoids [52] also exhibit blood-pressure-lowering effects. Flavonoids and tannins are phenolic compounds with well-known antioxidant biological activity, which could contribute to the reported anti-cancer properties.

2.3. Antioxidant Activity

The extract exhibits strong antioxidant activity measured through the Antioxidant Activity Index (AAI > 1). The antioxidant activity analysis is shown in Table 4.
The high antioxidant capacity of the extract can be ascribed to its phenolic content, similar to the polar extracts of other species (T. involucrata) [53].
Table 4. Antioxidant activity of T. volubilis methanolic extract.
Table 4. Antioxidant activity of T. volubilis methanolic extract.
TPC
mg GAE/
g Extract
ABTS
μmol TE/
g Extract
FRAP
μmol TE/
g Extract
DPPH
μmol TE/
g Extract
IC50
mg Extract/
mg DPPH
AAI
[DPPH] (μg mL−1)/IC50
127 ± 2 2004 ± 36 1250 ± 15585 ± 5 1.30 ± 0.06 1.14 ± 0.01
All values are average ± SD of three repetitions. TPC: Total Phenolic Content. GAE: Gallic acid equivalent. TE: Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) equivalent. ABTS: 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) method. FRAP: Ferric reducing antioxidant power. DPPH: 2,2-diphenyl-1-picrylhydrazyl method. IC50: Half maximal inhibitory concentration. AAI: Antioxidant Activity Index [54].

2.4. Compounds

From the dechlorophyllated methanolic extract, four compounds, (1) avicularin, (2) quercitrin, (3) afzelin, and (4) amentoflavone, were isolated through chromatographic techniques and identified through NMR spectroscopy. The structures are shown in Figure 3.
Avicularin was isolated by preparative TLC on direct silica F254 using 120 mL EtOAc:HOAc:H2O 18:1:1 (2.1 mg). Its RF was 0.65. The compound is a quercetin 3-O glycoside, where the sugar moiety is an arabinose unit. It was first isolated from the common knotgrass (Polygonum aviculare) and is considered to contribute to the hypoglycemic activity of Psidium guajava [55] and to the antibacterial and antifungal activity of Hypericum perforatum [56].
Quercitrin was isolated by preparative TLC on direct silica F254 using 120 mL DCM:MeOH 90:10 and two drops of water (5.6 mg). Its RF was 0.42. The compound is a quercetin 3-O glycoside, with rhamnose—a deoxy sugar—unit as the sugar moiety. It was isolated from oak (Quercus spp.), hence its name. It is used as a yellow dye and also as a bioactive product with varied biological effects [57].
Afzelin was isolated by preparative TLC on reverse-phase silica using MeOH:H2O 65:35 (3.3 mg). Its RF was 0.5. The compound is a kaempferol 3-O rhamnoside. It was first isolated from the fragrant water lily (Nymphaea odorata) [58]. It shows antibacterial and antitumor activity.
Amentoflavone was isolated as a yellow solid on Sephadex LH-20 on a microcolumn using MeOH:H2O 60:40 as eluent (2.2 mg). Its RF was 0.34. The compound is a biflavonoid: 3′-8″ apigenin, originally isolated from Ginkgo biloba. It is considered a multifunctional compound [59].
The 1H and 13C NMR spectra information of the identified compounds follows.
Avicularin (1): 1 H–NMR (500 MHz, CD3OD, δ ppm, J in Hertz): 3.50 (2H, m, H-5″), 3.86 (1H, m, H-4″), 3.91 (1H, dd, 5.4; 3.0, H-3″), 4.33 (1H, dd, 1.1; 3.0, H-2″), 5.47 (1H, d, 1.1, H-1″), 6.21 (1H, d, 2.1, H6), 6.40 (1H, d, 2.1, H-5′), 6.40 (1H, d, 2.1, H-8), 7.49 (1H, d, 8.4, H-6′), 7.53 (1H, d, 2.1, H-2′).
13C NMR (125 MHz, CD3OD, δ ppm, Carbon number): 61.3 (5″), 77.3 (3″), 82.0 (2″), 86.6 (4″), 93.4 (8), 98.6 (6), 104.3 (10), 108.2 (1″), 115.1 (2′), 115.6 (5′), 121.6 (1′), 121.7 (6′), 133.5 (3), 145.0 (3′), 148.9 (4′), 157.6 (9), 159.1 (2), 162.6 (5), 165.4 (7), 177.3 (4).
Quercitrin (2): 1H–NMR (500 MHz, CD3OD, δ ppm, J in Hertz): 0.93 (3H, d, 6.2, H-6″), 3.33 (1H, m, H-4″), 3.41 (1H, m, H-5″), 3.74 (1H, dd, 9.5 3.3, H-3″), 4.21 (1H, m, H-2″), 5.30 (1H, d, 1.1 H-1″), 6.19 (1H, d, 1.5, H-6), 6.35 (1H, brs, H-8), 6.90 (1H, d, 8.3, H-5′), 7.30 (1H, dd, 8.4 1.9, H-6′), 7.33 (1H, d, 1.8. H-2′).
13C NMR (125 MHz, CD3OD, δ ppm): 16.2 (6″), 70.5 (2″), 70.6 (3″), 70.7 (5″), 71.8 (4″), 93.4 (8), 98.5 (6), 104.5 (1″), 104.5 (10), 115.0 (5′), 115.5 (2′), 121.5 (6′), 121.6 (1′), 134.8 (3), 145.0 (3′), 148.5 (4′), 157.1 (9), 157.9 (2), 161.7 (5), 164.5 (7), 178.3 (4).
Afzelin (3): 1 H–NMR (500 MHz, Acetone D6, δ ppm, J in Hertz):
0.89 (3H, d 6, H-6″), 3.3 (1H, m, H-4″), 3.32 (1H, m, H-5″), 3.67 (1H, m, H-3″), 4.21 (1H, m, H-2″), 5.54 (1H, d 1.5, H-1″), 6.26 (1H, d 2.0, H-6), 6.47 (1H, d 2.0, H-8), 7.01 (1H, d 9, H-3″), 7.02 (1H, d 9, H-5′), 7.84 (1H, d 8.5, H-6′), 7.86 (1H, d 8.5, H-2′), 9.71 (1H, s, 5-OH).
13C NMR (Acetone D6, δ ppm): 16.9 (6″), 70.4 (5″), 70.6 (2″), 71.2 (3″), 72.1 (4″), 93.6 (8), 98.6 (6), 101.8 (1″), 104.5 (10), 115.4 (3′), 115.4 (5′), 121.7 (1′), 130.8 (2′), 130.8 (6′), 134.8 (3), 157.1 (4′), 157.5 (9), 159.9 (2), 162.4 (5), 164.2 (7).
Amentoflavone (4): 1 H–NMR (500 MHz, CD3OD, δ ppm, J in Hertz):
6.20 (1H, d, 2.4, H-6), 6.32 (1H, s, H-6″), 6.43 (1H, d, 2.4, 8), 6.60 (1H, s, H-3), 6.68 (1H, s, H-3″), 6.76 (1H, d, 8.2, H-3′′′), 6.76 (1H, d, 8.2, H-5′′′), 7.12 (1H, d, 8.2, H-5′), 7.70 (1H, d, 8.2, H-2′′′), 7.70 (1H, d, 8.2, H-6′′′), 7.94 (1H, dd, 2.2 8.4, H-6′), 8.22 (1H, d, 2.2, H-2′),
13C NMR (CD3OD, δ ppm): 94.9 (8), 99.9 (6), 100.9 (6″), 103.4 (3), 103.4 (3″), 104.3 (8″), 105.0 (10), 105.6 (10″), 116.3 (3′′′), 116.3 (5′′′), 118.5 (5′), 121.5 (3′), 123.3 (1′′′), 123.4 (1′), 127.5 (6′), 128.7 (2′′′), 128.7 (6′′′), 132.2 (2′), 159.0 (7), 159.0 (9), 159.0 (9″), 161.8 (4′′′), 162.1 (7″), 162.4 (2), 162.4 (4′), 164.4 (2″), 164.5 (5), 165.6 (5″), 183.0 (4″), 183.1 (4).
All the identified compounds exhibit potent antioxidant activity, which is summarized in Table 5.
The structure of the isolated compounds supports the antioxidant activity: they are all B-ring hydroxylated compounds, which is the most significant indicator of ROS and RNS scavenging activity, and the vicinal double OH groups in the B-ring of compounds 1 and 2 indicate strong lipid peroxidation inhibition [63]. Rhamnosides, though, present less metal-chelating activity than 6″OH glycosides [64].
Structure-activity relationships for cellular antioxidant effects are 3′,4′ o dihydroxyl group, 2,3 double bond conjugated with 4-keto group, and 3-hydroxyl group. Compounds 1 and 2 satisfy all the conditions.
Flavonols, such as compounds 1, 2, and 3, are among the most potent antibacterial flavonoids through mechanisms including interference with fatty acid elongation and are capable of synergistically reducing antibiotic resistance. Flavones such as 4 inhibit bacterial growth by forming complexes with cell wall components [65].
The isolated flavonoids show promising biological activity, which is exemplified in Table 6. There is a good overlap between the ethnopharmacological uses of T. volubilis and the biological activity of the identified compounds.
Compounds 2 and 3 exhibit biological effects in methanolic extracts due to their antioxidant capacity [70]. Compound 3 has undergone pre-clinical studies against lung cancer, also due to its antioxidant activity [75]. The antioxidant activity of Tragia spp. extracts underlie several ethnopharmacological uses which have been validated in vivo and have undergone clinical trials [76,77,78].
Extracts from the leaves of other Tragia species also contain potent antioxidant flavonoids, which are quercetin and kaempferol glycosides, for example, T. plukenetii [76] and T. involucrata [79]. Quercetin and kaempferol—which are metabolic products of their glycosides—are among the most frequently studied flavonoids and are recommended as dietary supplements due to their high biological activity [80].

3. Materials and Methods

3.1. Plant Material

Aerial parts of Tragia volubilis L. were collected in El Tambo, -Catamayo, Loja province in southern Ecuador. Coordinates: 04°07′13.3″ S; 79°18′11.9″ W; 1600 m ASL (Figure 4). Species identification was performed by Fani Tinitana, PhDPh.D., and a voucher specimen was deposited at the Herbarium of Universidad Técnica Particular de Loja, Ecuador. The specimen was collected in compliance with the Framework Contract MAE-DNB-CM-2016-0048 dated 20 September 2016. The plant material was dried for 7 days at 30 °C under airflow.

3.2. Preparation of the Extract

Because it is common for methanolic extracts to show higher biological activity than aqueous extracts [81], and the fact that methanol is the primary solvent used to date in Tragia species studies, with 47% of the studied Tragia spp. extracts [10], it was decideda decision was made to focus the present study on the methanolic extract rather than the aqueous extract, even though most ethnomedical uses employ aqueous extracts and decoctions. The dry plant material was extracted by static maceration for 3 days with analytical-grade methanol purchased from Merck, then filtered, and concentrated on a rotary evaporator (Buchi R210, Flawil, Switzerland) to yield the Tragia volubilis methanolic extract, which was stored at −18 °C.

3.3. Phytochemical Screening

The phytochemical screening of the extract was performed according to the methodology of Mandal et al. [82]. The Biuret copper -complex formation test was used for the detection of proteins; positive controls used were powdered milk, egg albumin, and glutamic acid. The Fehling test for reducing sugars was used for the detection of carbohydrates; positive controls were sucrose and glucose. Sudan fat-soluble dye was used for screening lipids; the positive control used was vegetable oil. The Dragendorff potassium tetraiodobismuthate test was used for alkaloids; the positive control was caffeine. The Lieberman Burchard acetic anhidride anhydride test was used for terpenoids; the: positive control was Argentatin B. The Shinoda magnesium and hydrochloric acid test was used for flavonoids; the positive control was hesperidin. The foam test was used for saponins; the: posivitepositive control was grated raw potato. The Bornträger test was used for quinones; the positive control was hydroquinone. The ferric chloride assay was used to test for phenolics-–tannins, with vanillin used as the positive control.

3.4. Antioxidant Activity

Total phenolic content was determined through the Folin-–Ciocâlteu method [83]. To a diluted sample of the extract, Folin-–Ciocâlteu reagent was added, and the wells were homogenized for 10 min. A total of 7.5% w/w Na2CO3 solution was added, and the wells were homogenized again for 5 min. Absorbance was measured at 760 nm on a Bio Tek Epoch 2 microplate reader (Winooski, VT, USA), and values were compared to a gallic acid calibration curve. Results are expressed in gallic acid equivalents (GAE) per gram of extract.
Antioxidant capacity was measured through the following tests: ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)) [84], FRAP (Ferric reducing antioxidant power) [85], and DPPH (2,2-diphenyl-1-picrylhydrazyl) methods [86]. All antioxidant activity was determined against a Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) standard. Antioxidant Activity Index (AAI) was calculated as the quotient between the final DPPH concentration and the IC50, providing a value that is independent of both the nature of the sample and DPPH concentrations [54]. AAI relates to antioxidant activity in plant extracts as follows: AAI < 0.5 is considered poor antioxidant activity. An AAI between 0.5 and 1.0 is considered moderate antioxidant activity. Values between 1.0 and 2.0 are considered high antioxidant activity, and an AAI > 2.0 is considered very high antioxidant activity. All tests were repeated three times, and the average values and standard deviation was were recorded.

3.5. Isolation of Secondary Metabolites

A sample of the methanolic extract was dechlorophyllated by open column chromatography on reverse phase silica RP-18 (40–63 µm) with methanol-:water 80:20 as eluent. A series of 20 mL portions were collected and then combined according to chromatographic similarity in eight fractions, of which fraction 2 was the most abundant. This fraction was further separated in open column chromatography using direct phase silica and ethyl acetate: methanol: water 90:4:1 as eluent. Fraction 4 was subject to further separation steps through Flash chromatography (Buchi Reveleris® PREP, Flawil, Switzerland) using an RP-18 silica column, and a methanol: water elution gradient from 40:60 to 70:30. From fraction 13, four compounds were isolated by preparative thin layer chromatography (PTLC).

3.6. Characterization and Identification of Secondary Metabolites

Isolated secondary metabolites were identified through 1H and 13C NMR spectra in a Bruker 500/125 MHz (Billerica, MA, USA) spectrometer using deuterated solvents: methanol and acetone. The spectra were complemented by 2D experiments: Homonuclear Correlation Spectroscopy (COSY), Total Correlation Spectroscopy (TOCSY), Heteronuclear Multiple Bond Correlation (HMBC), and Heteronuclear Multiple Quantum Correlation (HMQC), to aid with the structural elucidation. The candidate compound identity was confirmed by comparison with published results [87,88,89,90].

4. Conclusions

The phytochemical composition of T. volubilis has been partially determined for the first time. The phytochemical screening of the methanolic extract of the aerial parts of the species shows the presence of alkaloids, terpenoids, tannins, and flavonoids, similar to the composition of polar extracts from other species of the genus.
The methanolic extract shows strong antioxidant activity, which can be partially attributed to the presence of phenolic compounds. Four bioactive flavonoid compounds, avicularin, quercitrin, afzelin, and amentoflavone, have been isolated from the extract. These compounds exhibit biological activity that supports the reported ethnopharmacological uses of the plant, both in vitro and in vivo, and can be associated with their antioxidant bioactivity.
More studies are needed to completely determine the phytochemical makeup of T. volubilis, and to establish its biological activity and potential therapeutic use to fully validate the existing ethnopharmacological claims and develop better, low-toxicity treatments.

Author Contributions

Conceptualization, J.C.R.-B. and R.D.-C.; methodology, J.C.R.-B. and N.C.A.-V.; investigation, R.D.-C. and N.C.A.-V.; compound isolation and identification, N.C.A.-V., R.D.-C., and J.C.R.-B.; validation, J.C.R.-B.; writing—original draft preparation, R.D.-C.; writing—review and editing, J.C.R.-B. and R.D.-C. Resources, J.C.R.-B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

All relevant data is already in the article.

Acknowledgments

The authors are grateful to the Universidad Técnica Particular de Loja (UTPL) for supporting this research and open access publication.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shukla, S.S.; Jain, S.K.; Kalyani, G.; Gidwani, B.; Pandey, R.K.; Pandey, R.; Vyas, A. Zoopharmacognosy (Plant-Animal Interaction). In Evidence Based Validation of Traditional Medicines: A comprehensive Approach; Mandal, S.C., Chakraborty, R., Sen, S., Eds.; Springer: Singapore, 2021; pp. 727–741. ISBN 9789811581274. [Google Scholar]
  2. Solecki, R.S. Shanidar IV, a Neanderthal Flower Burial in Northern Iraq. Science 1975, 190, 880–881. [Google Scholar] [CrossRef]
  3. Ekor, M. The Growing Use of Herbal Medicines: Issues Relating to Adverse Reactions and Challenges in Monitoring Safety. Front. Pharmacol. 2014, 4, 177. [Google Scholar] [CrossRef]
  4. Vyas, S.; Kothari, S.L.; Kachhwaha, S. Nootropic Medicinal Plants: Therapeutic Alternatives for Alzheimer’s Disease. J. Herb. Med. 2019, 17–18, 100291. [Google Scholar] [CrossRef]
  5. Mwine, J.T.; Damme, P.V. Why Do Euphorbiaceae Tick as Medicinal Plants? A Review of Euphorbiaceae Family and Its Medicinal Features. J. Med. Plants Res. 2011, 5, 652–662. [Google Scholar]
  6. Kar, A.; Choudhary, B.K.; Bandyopadhyay, N.G. Comparative Evaluation of Hypoglycaemic Activity of Some Indian Medicinal Plants in Alloxan Diabetic Rats. J. Ethnopharmacol. 2003, 84, 105–108. [Google Scholar] [CrossRef]
  7. Narasimhan, S. Pharmacological Potential of the Stinging Plant Tragia Species: A Review. Pharmacogn. J. 2021, 13, 278–284. [Google Scholar] [CrossRef]
  8. Ruffo, C.K.; Birnie, A.; Tengnäs, B. Edible Wild Plants of Tanzania; Regional Land Management Unit/Sida: Nairobi, Kenya, 2002; ISBN 978-9966-896-62-9. [Google Scholar]
  9. Nath, T.M.; Das, S.; Zothanpuia; Chattopadhyay, P. Investigating the Effects of Dermal Exposure to In-Vivo Animal Models on the Riot-Control Properties of a Powder Formulation of Tragia Involucrata Leaf Hair Lining. Cutan. Ocul. Toxicol. 2023, 42, 151–161. [Google Scholar] [CrossRef]
  10. Duarte-Casar, R.; Romero-Benavides, J.C.; Tragia, L. Genus: Ethnopharmacological Use, Phytochemical Composition and Biological Activity. Plants 2021, 10, 2717. [Google Scholar] [CrossRef]
  11. Elmore, F.H. The Ethnobotany of the Kayenta Navaho. An Analysis of the John and Louisa Wetherill Ethnobotanical Collections. Leland C. Wyman and Stuart K. Harris. University of New Mexico Publications in Biology, Number Five. The University of New Mexico Press, Albuquerque, 1951. 66pp. Am. Antiq. 1952, 17, 276. [Google Scholar] [CrossRef]
  12. Hernández, F. Historia de las Plantas de Nueva España; Imprenta Universitaria: Mexico City, Mexico, 1943; Volume 2. [Google Scholar]
  13. Moges, A.; Moges, Y. Ethiopian Common Medicinal Plants: Their Parts and Uses in Traditional Medicine—Ecology and Quality Control. In Plant Science—Structure, Anatomy and Physiology in Plants Cultured In Vivo and In Vitro; Gonzalez, A., Rodriguez, M., Gören Sağlam, N., Eds.; IntechOpen: London, UK, 2020; ISBN 978-1-78984-746-8. [Google Scholar]
  14. Novara, L. Flora Del Valle de Lerma: Euphorbiaceae. Aportes Bot. Salta Ser. Flora 2013, 11, 1–188. [Google Scholar]
  15. Dalfonso, C.; Scaramuzzino, R. Flora Medicinal de Las Sierras de Azul (Sistema de Tandilia): Catálogo, Importancia y Su Relación Con Las Actividades Antrópicas; UNCPBA: Tandil, Buenos Aires, Argentina, 2012. [Google Scholar]
  16. González-Rodríguez, H.; Maiti, R.; Kumari, A. Nutrient Profile of Native Woody Species and Medicinal Plants in Northeastern Mexico: A Synthesis. J. Bioprocess. Biotech. 2016, 6, 283. [Google Scholar] [CrossRef]
  17. Swank, G. The Ethnobotany of the Acoma and Laguna Indians. Master’s Thesis, University of New Mexico, Albuquerque, NM, USA, 1932. Biology ETDs. [Google Scholar]
  18. Silberbauer-Gottsberger, I. O Cerrado Como Potencial de Plantas Medicinais e Tóxicas. Oréades 1982, 8, 15–30. [Google Scholar]
  19. Arnason, T.; Uck, F.; Lambert, J.; Hebda, R. Maya Medicinal Plants of San Jose Succotz, Belize. J. Ethnopharmacol. 1980, 2, 345–364. [Google Scholar] [CrossRef] [PubMed]
  20. Kapere, K.N.; Mugisha, M.K.; Tweheyo, O.A.; Waisindye, N. Community Perceptions on the Use of Traditional Medicine among People Experiencing Sexual Dysfunctions in Greater Mbarara, Western Uganda. J. Pharmacogn. Phytochem. 2022, 11, 46–59. [Google Scholar]
  21. Carlomagno, A.; Pardini, A.; Esquijerosa, Y.C. Medicinal Plants in Ethnobotanical and Religious Traditions in Cuba: A First Review and Updating; Associazione Scienze Agrarie Tropicali: Ragusa, Italy, 2015; p. 21. [Google Scholar]
  22. Miller, K.I.; Webster, G.L. A Preliminary Revision of Tragia (Euphorbiaceae) in the United States. Rhodora 1967, 69, 241–305. [Google Scholar]
  23. Tropicos.org Missouri Botanical Garden. !Tragia Volubilis L. Available online: http://legacy.tropicos.org/Name/12801898?projectid=56 (accessed on 30 June 2023).
  24. Gillespie, L.J.; Armbruster, W.S. A Contribution to the Guianan Flora: Dalechampia, Haematostemon, Omphalea, Pera, Plukenetia, and Tragia (Euphorbiaceae) with Notes on Subfamily Acalyphoideae. Smithson. Contrib. Bot. 1997, 86, 77507. [Google Scholar] [CrossRef]
  25. POWO Tragia Plum. Ex L.|Plants of the World Online|Kew Science. Available online: http://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:327688-2 (accessed on 25 October 2021).
  26. Pardo-Castello, V. Dermatitis Venenata: A Study of the Tropical Plants Producing Dermatitis. JAMA Dermatol. 1923, 7, 81–90. [Google Scholar] [CrossRef]
  27. Thurston, E.L.; Lersten, N.R. The Morphology and Toxicology of Plant Stinging Hairs. Bot. Rev. 1969, 35, 393–412. [Google Scholar] [CrossRef]
  28. Marineros, L.; Vega, H. Contribución al Conocimiento de Algunas Plantas Urticantes de Importancia Médica En Honduras. Sci. Hondurensis 2021, 4, 8–19. [Google Scholar]
  29. Mulgura de Romero, M.E.; de Sanguinetti, M.M.G. Actualizacion Taxonómica de Tragia (Euphorbiaceae) Para Argentina y Regiones Limítrofes. Darwiniana 1989, 29, 77–138. [Google Scholar]
  30. Reko, B. La Hierba de Quetzalcoatl. Bot. Sci. 1946, 4, 13–14. [Google Scholar] [CrossRef]
  31. Jiofack, T.; Fokunang, C.; Guedje, N.M.; Victor, K.; Evariste, F.; Nkongmeneck, B.; Mapongmetsem, P.; Tsabang, N. Ethnobotanical Uses of Some Plants of Two Ethnoecological Regions of Cameroon. Int. J. Med. Sci. 2010, 2, 60–79. [Google Scholar]
  32. Fonnegra-Gómez, R.; Villa-Londoño, J.; Fonnegra, Z.I.M. Plantas Usadas Como Medicinales En El Altiplano Del Oriente Antioqueño—Colombia; Herbario Universidad de Antioquia: Antioquia, Colombia, 2012; ISBN 978-958-8790-36-7. [Google Scholar]
  33. Corrêa, M.P. Dicionário das Plantas Úteis do BRASIL e das Exóticas Cultivadas; Imprensa Nacional: Rio de Janeiro, Brazil, 1926; Volume 2.
  34. Cunha Lima, S.; Rodrigues, E.; Melo, T.; Nascimento, A.; Guedes, M.; Cruz, T.; Alves, C.; Meyer, R. Levantamento da flora medicinal usada no tratamento de doenças metabólicas em Salvador, BA Brasil. Rev. Bras. Plantas Med. 2008, 10, 83–89. [Google Scholar]
  35. Posthouwer, C.; Verheijden, T.M.S.; van Andel, T.R. A Rapid Sustainability Assessment of Wild Plant Extraction on the Dutch Caribbean Island of St. Eustatius. Econ. Bot. 2016, 70, 320–331. [Google Scholar] [CrossRef]
  36. Barboza, G.E.; Cantero, J.J.; Núñez, C.; Pacciaroni, A.; Espinar, L.A. Medicinal Plants: A General Review and a Phytochemical and Ethnopharmacological Screening of the Native Argentine Flora. Kurtziana 2009, 34, 7–365. [Google Scholar]
  37. Mesa, R.Y.; Tomás, J. Plantas Medicinales, Aromáticas o Venenosas de Cuba, 2nd ed.; Ciencia y Técnica: Havana, Cuba, 1974. [Google Scholar]
  38. Morton, J.F. Atlas of Medicinal Plants of Middle America: Bahamas to Yucatan; C. C. Thomas: Springfield, IL, USA, 1980; ISBN 978-0-398-04036-9. [Google Scholar]
  39. Pájaro-González, Y.; Oliveros-Díaz, A.F.; Cabrera-Barraza, J.; Cerra-Dominguez, J.; Díaz-Castillo, F. Chapter 1—A Review of Medicinal Plants Used as Antimicrobials in Colombia. In Medicinal Plants as Anti-Infectives; Chassagne, F., Ed.; Academic Press: Cambridge, MA, USA, 2022; pp. 3–57. ISBN 978-0-323-90999-0. [Google Scholar]
  40. Digital Science Dimensions. Available online: https://app.dimensions.ai/ (accessed on 25 May 2022).
  41. De Souza, P.; Mariano, L.N.B.; Cechinel-Zanchett, C.C.; Cechinel-Filho, V. Promising Medicinal Plants with Diuretic Potential Used in Brazil: State of the Art, Challenges, and Prospects. Planta Medica 2021, 87, 24–37. [Google Scholar] [CrossRef]
  42. Lima, S.T.C.; Merrigan, T.L.; Rodrigues, E.D. Synthetic and Plant Derived Thyroid Hormone Analogs. In Thyroid and Parathyroid Diseases—New Insights into Some Old and Some New Issues; Ward, L., Ed.; InTech: Houston, TX, USA, 2012; ISBN 978-953-51-0221-2. [Google Scholar]
  43. Nawaz, H.; Aslam, M.; Shahzad, H. Mehboob Comparative Evaluation of Phytochemical Composition and Antioxidant Potential of Some Medicinally-Important Euphorbiaceous Plants. J. Anim. Plant Sci. 2022, 32, 1703–1712. [Google Scholar] [CrossRef]
  44. Varma, G.G.; Mathai, B.K.; Das, K.; Gowda, G.; Rammohan, S.; Einstein, J.W. Evaluation of Antiepileptic Activity of Methanolic Leaves Extract of Tragia Involucrata Linn. in Mice. Int. Lett. Nat. Sci. 2014, 12, 167–179. [Google Scholar] [CrossRef]
  45. Samy, R.P.; Gopalakrishnakone, P.; Sarumathi, M.; Ignacimuthu, S. Wound Healing Potential of Tragia Involucrata Extract in Rats. Fitoterapia 2006, 77, 300–302. [Google Scholar] [CrossRef]
  46. Pallie, M.S.; Perera, P.K.; Kumarasinghe, N.; Arawwawala, M.; Goonasekara, C.L. Ethnopharmacological Use and Biological Activities of Tragia Involucrata L. Evid. Based Complement. Altern. Med. 2020, 2020, 8848676. [Google Scholar] [CrossRef]
  47. Menon, M.; Varghese, L. Evaluation of the Phytochemical Constituents and Tumor Reduction Potentials of Tragia Involucrata Linn. J. App Biol. Biotech. 2023, 11, 84–91. [Google Scholar] [CrossRef]
  48. Mothana, R.A.A.; Abdo, S.A.A.; Hasson, S.; Althawab, F.M.N.; Alaghbari, S.A.Z.; Lindequist, U. Antimicrobial, Antioxidant and Cytotoxic Activities and Phytochemical Screening of Some Yemeni Medicinal Plants. Evid. Based Complement. Altern. Med. 2010, 7, 323–330. [Google Scholar] [CrossRef] [PubMed]
  49. Oladosu, I.A.; Balogun, S.O.; Ademowo, G.O. Phytochemical Screening, Antimalarial and Histopathological Studies of Allophylus Africanus and Tragia Benthamii. Chin. J. Nat. Med. 2013, 11, 371–376. [Google Scholar] [CrossRef] [PubMed]
  50. Álvarez-Martínez, F.J.; Barrajón-Catalán, E.; Herranz-López, M.; Micol, V. Antibacterial Plant Compounds, Extracts and Essential Oils: An Updated Review on Their Effects and Putative Mechanisms of Action. Phytomedicine 2021, 90, 153626. [Google Scholar] [CrossRef]
  51. Maaliki, D.; Shaito, A.A.; Pintus, G.; El-Yazbi, A.; Eid, A.H. Flavonoids in Hypertension: A Brief Review of the Underlying Mechanisms. Curr. Opin. Pharmacol. 2019, 45, 57–65. [Google Scholar] [CrossRef]
  52. Perveen, S.; Al-Taweel, A.M. Terpenes and Terpenoids: Recent Advances; IntechOpen: London, UK, 2021; ISBN 978-1-83881-916-3. [Google Scholar]
  53. Velu, V.; Banerjee, S.; Radhakrishnan, V.; Gupta, G.; Chellappan, D.K.; Fuloria, N.K.; Fuloria, S.; Mehta, M.; Dua, K.; Malipeddi, H. Identification of Phytoconstituents of Tragia Involucrata Leaf Extracts and Evaluate Their Correlation with Anti-Inflammatory & Antioxidant Properties. Anti-Inflamm. Anti-Allergy Agents Med. Chem. 2021, 20, 308–315. [Google Scholar] [CrossRef]
  54. Scherer, R.; Teixeira Godoy, H. Antioxidant Activity Index (AAI) by the 2,2-Diphenyl-1-Picrylhydrazyl Method. Food Chem. 2009, 112, 654–658. [Google Scholar] [CrossRef]
  55. Mendoza-Meneses, C.J.; Burgos-Araiza, A.K.; Feregrino-Pérez, A.A. Chapter 18—Antidiabetic Herbal Biomolecules. In Herbal Biomolecules in Healthcare Applications; Mandal, S.C., Nayak, A.K., Dhara, A.K., Eds.; Academic Press: Cambridge, MA, USA, 2022; pp. 407–434. ISBN 978-0-323-85852-6. [Google Scholar]
  56. Saddiqe, Z.; Naeem, I.; Maimoona, A. A Review of the Antibacterial Activity of Hypericum Perforatum L. J. Ethnopharmacol. 2010, 131, 511–521. [Google Scholar] [CrossRef]
  57. Chen, J.; Li, G.; Sun, C.; Peng, F.; Yu, L.; Chen, Y.; Tan, Y.; Cao, X.; Tang, Y.; Xie, X.; et al. Chemistry, Pharmacokinetics, Pharmacological Activities, and Toxicity of Quercitrin. Phytother. Res. 2022, 36, 1545–1575. [Google Scholar] [CrossRef]
  58. Zhang, Z.; ElSohly, H.N.; Li, X.-C.; Khan, S.I.; Broedel, S.E.; Raulli, R.E.; Cihlar, R.L.; Burandt, C.; Walker, L.A. Phenolic Compounds from Nymphaea Odorata. J. Nat. Prod. 2003, 66, 548–550. [Google Scholar] [CrossRef]
  59. Xiong, X.; Tang, N.; Lai, X.; Zhang, J.; Wen, W.; Li, X.; Li, A.; Wu, Y.; Liu, Z. Insights into Amentoflavone: A Natural Multifunctional Biflavonoid. Front. Pharmacol. 2021, 12, 768708. [Google Scholar] [CrossRef] [PubMed]
  60. Zhang, Q.; Yang, W.; Liu, J.; Liu, H.; Lv, Z.; Zhang, C.; Chen, D.; Jiao, Z. Identification of Six Flavonoids as Novel Cellular Antioxidants and Their Structure-Activity Relationship. Oxidative Med. Cell. Longev. 2020, 2020, e4150897. [Google Scholar] [CrossRef] [PubMed]
  61. Tatsimo, S.J.N.; Tamokou, J.d.D.; Havyarimana, L.; Csupor, D.; Forgo, P.; Hohmann, J.; Kuiate, J.-R.; Tane, P. Antimicrobial and Antioxidant Activity of Kaempferol Rhamnoside Derivatives from Bryophyllum Pinnatum. BMC Res. Notes 2012, 5, 158. [Google Scholar] [CrossRef]
  62. Frota, L.S.; Alves, D.R.; Marinho, M.M.; Da Silva, L.P.; de Queiroz Almeida Neto, F.W.; Marinho, E.S.; De Morais, S.M. Antioxidant and Anticholinesterase Activities of Amentoflavone Isolated from Ouratea Fieldingiana (Gardner) Engl. through In Vitro and Chemical-Quantum Studies. J. Biomol. Struct. Dyn. 2023, 41, 1206–1216. [Google Scholar] [CrossRef] [PubMed]
  63. Heim, K.C.; Tagliaferro, A.R.; Heim, K.E.; Tagliaferro, A.R.; Bobilya, D.J. Flavonoid Antioxidants: Chemistry, Metabolism and Structure-Activity Relationships. J. Nutr. Biochem. 2002, 13, 572–584. [Google Scholar] [CrossRef]
  64. Li, X.; Jiang, Q.; Wang, T.; Liu, J.; Chen, D. Comparison of the Antioxidant Effects of Quercitrin and Isoquercitrin: Understanding the Role of the 6″-OH Group. Molecules 2016, 21, 1246. [Google Scholar] [CrossRef]
  65. Farhadi, F.; Khameneh, B.; Iranshahi, M.; Iranshahy, M. Antibacterial Activity of Flavonoids and Their Structure–Activity Relationship: An Update Review. Phytother. Res. 2019, 33, 13–40. [Google Scholar] [CrossRef]
  66. da Silva Sa, F.A.; de Paula, J.A.M.; dos Santos, P.A.; de Almeida Ribeiro Oliveira, L.; de Almeida Ribeiro Oliveira, G.; Liao, L.M.; de Paula, J.R.; do Rosario Rodrigues Silva, M. Phytochemical Analysis and Antimicrobial Activity of Myrcia Tomentosa (Aubl.) DC. Leaves. Molecules 2017, 22, 1100. [Google Scholar] [CrossRef]
  67. Wang, Y.; Liu, M.; Chen, S.; Wu, Q. Avicularin Inhibits Cell Proliferation and Induces Cell Apoptosis in Cutaneous Squamous Cell Carcinoma. Exp. Ther. Med. 2019, 19, 1065–1071. [Google Scholar] [CrossRef]
  68. Wang, W.; Zheng, H.; Zheng, M.; Liu, X.; Yu, J. Protective Effect of Avicularin on Rheumatoid Arthritis and Its Associated Mechanisms. Exp. Ther. Med. 2018, 16, 5343–5349. [Google Scholar] [CrossRef]
  69. Babujanarthanam, R.; Kavitha, P.; Pandian, M.R. Quercitrin, a Bioflavonoid Improves Glucose Homeostasis in Streptozotocin-Induced Diabetic Tissues by Altering Glycolytic and Gluconeogenic Enzymes. Fundam. Clin. Pharmacol. 2010, 24, 357–364. [Google Scholar] [CrossRef]
  70. de Barros, M.; da Silva, L.M.; Boeing, T.; Somensi, L.B.; Cury, B.J.; de Moura Burci, L.; Santin, J.R.; de Andrade, S.F.; Monache, F.D.; Cechinel-Filho, V. Pharmacological Reports about Gastroprotective Effects of Methanolic Extract from Leaves of Solidago Chilensis (Brazilian Arnica) and Its Components Quercitrin and Afzelin in Rodents. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2016, 389, 403–417. [Google Scholar] [CrossRef] [PubMed]
  71. Lee, S.Y.; So, Y.-J.; Shin, M.S.; Cho, J.Y.; Lee, J. Antibacterial Effects of Afzelin Isolated from Cornus Macrophylla on Pseudomonas Aeruginosa, A Leading Cause of Illness in Immunocompromised Individuals. Molecules 2014, 19, 3173–3180. [Google Scholar] [CrossRef] [PubMed]
  72. Cechinel-Zanchett, C.C.; Mariano, L.N.B.; Boeing, T.; da Costa, J.d.C.; Da Silva, L.M.; Bastos, J.K.; Cechinel-Filho, V.; de Souza, P. Diuretic and Renal Protective Effect of Kaempferol 3-O-Alpha-l-Rhamnoside (Afzelin) in Normotensive and Hypertensive Rats. J. Nat. Prod. 2020, 83, 1980–1989. [Google Scholar] [CrossRef] [PubMed]
  73. Ndongo, J.T.; Issa, M.E.; Messi, A.N.; Mbing, J.N.; Cuendet, M.; Pegnyemb, D.E.; Bochet, C.G. Cytotoxic Flavonoids and Other Constituents from the Stem Bark of Ochna Schweinfurthiana. Nat. Prod. Res. 2015, 29, 1684–1687. [Google Scholar] [CrossRef] [PubMed]
  74. Vasconcelos, C.C.; Lopes, A.J.O.; Sousa, E.L.F.; Camelo, D.S.; Lima, F.C.V.M.; da Rocha, C.Q.; Silva, G.E.B.; Garcia, J.B.S.; de Sousa Cartágenes, M.D.S. Effects of Extract of Arrabidaea Chica Verlot on an Experimental Model of Osteoarthritis. Int. J. Mol. Sci. 2019, 20, 4717. [Google Scholar] [CrossRef] [PubMed]
  75. Cao, M.; Fan, B.; Zhen, T.; Wang, J. A Pre-Clinical Trial Study on Afzelin: Anti-Human Lung Cancer, Anti-Cholinesterase, and Anti-Glucosidase Properties. Arch. Med. Sci. 2021. [Google Scholar] [CrossRef]
  76. Bonam, S.; Manoharan, S.; Pandy, V.; Raya, A.; Nadendla, R.; Jagadeesan, M.; Babu, A. Phytochemical, in Vitro Antioxidant and In Vivo Safety Evaluation of Leaf Extracts of Tragia Plukenetii. Pharmacogn. J. 2019, 11, 338–345. [Google Scholar] [CrossRef]
  77. Alanazi, A.; Anwar, M.J.; Ahmad, M.A. Hepatoprotective and Antioxidant Activity of Tragia Involucrata Root Extracts against CCl4 Induced Hepatotoxicity in Rats. Pharm. Lett. 2015, 7, 146–152. [Google Scholar]
  78. Pallie, M.; Perera, P.; Goonasekara, C.; Kumarasinghe, N.; Arawwawala, M. Efficacy and Safety of Freeze-Dried Form of Tragia Involucrata L. Decoction in Treating Diabetes: A Randomized Controlled Clinical Trial. Clin. Trials Degener. Dis. 2020, 5, 31–36. [Google Scholar] [CrossRef]
  79. Sulaiman, T.; Balachandran, I. LC/MS Characterization of Antioxidant Flavonoids from Tragia Involucrata L. Beni-Suef Univ. J. Basic Appl. Sci. 2016, 5, 231–235. [Google Scholar] [CrossRef]
  80. Jan, R.; Khan, M.; Asaf, S.; Lubna; Asif, S.; Kim, K.-M. Bioactivity and Therapeutic Potential of Kaempferol and Quercetin: New Insights for Plant and Human Health. Plants 2022, 11, 2623. [Google Scholar] [CrossRef] [PubMed]
  81. Ibrahim, N.; Kebede, A. In Vitro Antibacterial Activities of Methanol and Aqueous Leave Extracts of Selected Medicinal Plants against Human Pathogenic Bacteria. Saudi J. Biol. Sci. 2020, 27, 2261–2268. [Google Scholar] [CrossRef]
  82. Mandal, S.C.; Mandal, V.; Das, A.K. Qualitative Phytochemical Screening. In Essentials of Botanical Extraction; Elsevier: Amsterdam, The Netherlands, 2015; pp. 173–185. ISBN 978-0-12-802325-9. [Google Scholar]
  83. Singleton, V.L.; Rossi, J.A. Colorimetry of Total Phenolics with Phosphomolybdic-Phosphotungstic Acid Reagents. Am. J. Enol. Vitic. 1965, 16, 144–158. [Google Scholar] [CrossRef]
  84. Floegel, A.; Kim, D.-O.; Chung, S.-J.; Koo, S.I.; Chun, O.K. Comparison of ABTS/DPPH Assays to Measure Antioxidant Capacity in Popular Antioxidant-Rich US Foods. J. Food Compos. Anal. 2011, 24, 1043–1048. [Google Scholar] [CrossRef]
  85. Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef]
  86. Figueroa, J.G.; Borrás-Linares, I.; Del Pino-García, R.; Curiel, J.A.; Lozano-Sánchez, J.; Segura-Carretero, A. Functional Ingredient from Avocado Peel: Microwave-Assisted Extraction, Characterization and Potential Applications for the Food Industry. Food Chem. 2021, 352, 129300. [Google Scholar] [CrossRef]
  87. Ahn, S.; Jung, H.; Jung, Y.; Lee, J.; Shin, S.Y.; Lim, Y.; Lee, Y.H. Identification of the Active Components Inhibiting the Expression of Matrix Metallopeptidase-9 by TNFα in Ethyl Acetate Extract of Euphorbia Humifusa Willd. J. Appl. Biol. Chem. 2019, 62, 367–374. [Google Scholar] [CrossRef]
  88. Hardiyanti, R.; Marpaung, L.; Adnyana, I.K.; Simanjuntak, P. Isolation of Quercitrin from Dendrophthoe Pentandra (L.) Miq Leaves Ans Its Antioxidant and Antibacterial Activities. RJC 2019, 12, 1822–1827. [Google Scholar] [CrossRef]
  89. Hanrahan, J.R.; Chebib, M.; Davucheron, N.L.M.; Hall, B.J.; Johnston, G.A.R. Semisynthetic Preparation of Amentoflavone: A Negative Modulator at GABA(A) Receptors. Bioorg Med. Chem. Lett. 2003, 13, 2281–2284. [Google Scholar] [CrossRef]
  90. Le, T.-K.-D.; Hao, B.; Nguyen, T.; Pham, T.; Duong, H. Chemical Constituents of Euphorbia Tirucalli L. Sci. Technol. Dev. J.—Nat. Sci. 2019, 2, 76–82. [Google Scholar] [CrossRef]
Figure 1. Geographical distribution of T. volubilis. Green: native. Light green: possibly introduced. Source [25].
Figure 1. Geographical distribution of T. volubilis. Green: native. Light green: possibly introduced. Source [25].
Plants 12 03139 g001
Figure 2. Tragia volubilis plant, showing serrated leaves and stinging hairs. Photo by Sebastien Sant, CC-BY-NC-4.0. French Guiana, France.
Figure 2. Tragia volubilis plant, showing serrated leaves and stinging hairs. Photo by Sebastien Sant, CC-BY-NC-4.0. French Guiana, France.
Plants 12 03139 g002
Figure 3. Compounds isolated from T. volubilis methanolic extract.
Figure 3. Compounds isolated from T. volubilis methanolic extract.
Plants 12 03139 g003
Figure 4. Collection area of T. volubilis L. used in this study.
Figure 4. Collection area of T. volubilis L. used in this study.
Plants 12 03139 g004
Table 1. Traditional uses of New World Tragia species.
Table 1. Traditional uses of New World Tragia species.
SpeciesRegionUsesRefs.
Tragia cordata Michx.USAUrinary tract conditions[13]
Tragia geraniifolia Klotzsch ex Müll. Arg.Bolivia, Paraguay, Uruguay, ArgentinaEmollient[14]
Tragia nepetifolia Cav.USA, MexicoSnakebite[11]
Tragia pinnata (Poir.) A. Juss.Brazil, ArgentinaEmollient[15]
Tragia ramosa Torr.USA, MexicoAnt bite[16,17]
Tragia uberabana Müll. Arg. BrazilNS[18]
Tragia volubilis L. Mexico to ArgentinaSee below[10]
Tragia yucatanensis Millsp. Mexico, Belize, HondurasBurns, rheumatism[19]
Table 2. Ethnomedical uses of Tragia volubilis L.
Table 2. Ethnomedical uses of Tragia volubilis L.
UsePlant OrganCountryPreparation/AdministrationRefs.
AnalgesicStem, leavesCameroonDecoction[31]
AntirheumaticLeaves, branchesColombiaLightly whip affected joints[32]
Anti-ulcerNSBrazilNS[33]
Blood pressureLeafBrazilInfusion; oral[34]
Cancer preventionLeafDutchCaribbeanInfusion, oral[35]
DiureticNSArgentinaNS[36]
FertilityStem, leavesCameroonDecoction[31]
Skin ulcersAerial partsCubaPlant juice mixed with salt, topical[37]
SudorificRootCubaDecoction, oral[37,38]
Venereal diseasesLeavesMexicoDecoction, NS[30]
Venereal diseasesRootCubaDecoction, NS[37]
Wound anti-infectiveBranches with leavesColombiaNS, oral[39]
Wound anti-infectiveBranches with leavesColombiaDecoction, topical[32]
NS: not specified.
Table 3. Phytochemical screening of T. volubilis methanolic extract.
Table 3. Phytochemical screening of T. volubilis methanolic extract.
Compound FamilyPresenceTest
ProteinBiuret
Carbohydrates++Fehling
FatsSudan
Alkaloids+++Dragendorff
Terpenoids+Lieberman Burchard
Flavonoids++Shinoda
SaponinsFoam
QuinonesBornträger
Tannins +++Ferric Chloride Assay
−: Absence. +: Small presence. ++: Medium presence. +++: Strong presence.
Table 5. Antioxidant activity of compounds 14.
Table 5. Antioxidant activity of compounds 14.
CompoundDPPH IC50 (µM)Refs.
171.68 ± 0.06[60]
268.26 ± 1.37[60]
314.89 ± 1.71[61]
410.64 ± 0.15[62]
Table 6. Selected biological activities of isolated compounds from T. volubilis.
Table 6. Selected biological activities of isolated compounds from T. volubilis.
CompoundActivityBiological ModelEffectRefs.
Avicularin (1)Anti-fungalCandida albicans.MIC: 4 μg/mL[66]
AntiproliferativeSCC13 cellsDose and time-dependent apoptosis induction[67]
AntirheumaticHuman synovial Rheumatoid arthritis cells Dose-dependent viability inhibition and apoptosis induction[68]
Quercitrin (2)AntidiabeticMale albino Wistar rats, streptomycin-induced diabetesGlucose homeostasis improvement (p < 0.05) effect at 30 mg/kg dose. [69]
Anti-ulcerFemale Swiss mice1.38 mg/kg reduces MPO activity[70]
Afzelin (3)AntibacterialPseudomonas aeruginosaMIC: 31 µg/mL[71]
DiureticFemale Wistar ratsCalcium-sparing diuretic activity. Nephroprotective[72]
Anti-ulcerFemale Swiss mice0.078 mg/kg reduces MPO activity[70]
Amentoflavone (4)CytotoxicHeLa cellsIC50 20.7 μM[73]
AntirheumaticOsteoarthritis-induced Wistar ratsImprovements in incapacitation,
motor activity, allodynia, and
hyperalgesia parameters
[74]
Notes: MPO: Myeloperoxidase; MIC: minimum inhibitory concentration; IC50: 50% inhibitory concentration.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Romero-Benavides, J.C.; Atiencie-Valarezo, N.C.; Duarte-Casar, R. Flavonoid Composition and Antioxidant Activity of Tragia volubilis L. Methanolic Extract. Plants 2023, 12, 3139. https://doi.org/10.3390/plants12173139

AMA Style

Romero-Benavides JC, Atiencie-Valarezo NC, Duarte-Casar R. Flavonoid Composition and Antioxidant Activity of Tragia volubilis L. Methanolic Extract. Plants. 2023; 12(17):3139. https://doi.org/10.3390/plants12173139

Chicago/Turabian Style

Romero-Benavides, Juan Carlos, Nora Cecilia Atiencie-Valarezo, and Rodrigo Duarte-Casar. 2023. "Flavonoid Composition and Antioxidant Activity of Tragia volubilis L. Methanolic Extract" Plants 12, no. 17: 3139. https://doi.org/10.3390/plants12173139

APA Style

Romero-Benavides, J. C., Atiencie-Valarezo, N. C., & Duarte-Casar, R. (2023). Flavonoid Composition and Antioxidant Activity of Tragia volubilis L. Methanolic Extract. Plants, 12(17), 3139. https://doi.org/10.3390/plants12173139

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop